CoChat

The Impact of Restrictive Entry Criterion During the Placebo Lead‐in Period

Landin, R., DeBrota, D. J., DeVries, T. A., Potter, W. Z., Demitrack, M. A. · 2000 · Biometrics
Cited by 57

The DOI matches its Crossref record.

Abstract

Summary. In the study of depression, most randomized clinical trials have design features that attempt to sample from a stable patient population. One commonly used design feature is to require patients to maintain some minimum baseline symptom severity score during a placebo lead‐in period. One intent of this design feature is to evaluate the behavior of patients prior to administration of active medication. If, during the lead‐in period, patients do not maintain minimum symptom severity, the patients are excluded from the remainder of the study, the theory being that the excluded patients are not part of a stable patient population and hence are not likely to demonstrate efficacy of a truly effective treatment. This presentation investigates the effectiveness of a restrictive entry criterion and proposes an alternative explanation for what is usually defined as placebo response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.0006-341x.2000.00271.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 57

Metadata

Authors
Landin, R., DeBrota, D. J., DeVries, T. A., Potter, W. Z., & Demitrack, M. A.
Venue
Biometrics
Published
2000-03
Volume
56
Issue
1
Pages
271-278
ISSN
  • 0006-341X (ISSN-L)
  • 1541-0420
OpenAlex
W2098616868
Cited by
57
References
0
FWCI
1.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Impact of Restrictive Entry Criterion During the Placebo Lead‐in Period. https://app.cochat.ai/papers/10.1111/j.0006-341x.2000.00271.x
The paper
Landin, R., DeBrota, D. J., DeVries, T. A., Potter, W. Z., & Demitrack, M. A. (2000). The Impact of Restrictive Entry Criterion During the Placebo Lead‐in Period. Biometrics. https://doi.org/10.1111/j.0006-341x.2000.00271.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.